I. B. Mcinnes, B. P. Leung, R. D. Sturrock, M. Field, and F. Y. Liew, Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-a production in rheumatoid arthritis, Nat Med, vol.3, pp.189-95, 1997.

T. Ohteki, H. Tada, and K. Ishida, Essential roles of DCderived IL-15 as a mediator of inflammatory responses in vivo, J Exp Med, vol.203, pp.2329-2367, 2006.

M. Ziolkowska, A. Koc, and G. Luszczykiewicz, High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism, J Immunol, vol.164, pp.2832-2840, 2000.

T. A. Waldmann, The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design, Nat Rev Immunol, vol.6, pp.595-601, 2006.

S. Bulfone-paus, D. Ungureanu, and T. Pohl, Interleukin-15 protects from lethal apoptosis in vivo, Nat Med, vol.3, pp.1124-1132, 1997.

T. Yajima, K. Yoshihara, and K. Nakazato, IL-15 regulates CD8 + T cell contraction during primary infection, J Immunol, vol.176, pp.507-522, 2006.

S. Dubois, J. Mariner, T. A. Waldmann, and Y. Tagaya, IL-15Ra recycles and presents IL15 in trans to neighboring cells, Immunity, vol.17, pp.537-584, 2002.

T. Yajima, H. Nishimura, and W. Wajjwalku, Overexpression of interleukin-15 in vivo enhances antitumor activity against MHC class I-negative and -positive malignant melanoma through augmented www.aacrjournals.org NK activity and cytotoxic T-cell response, Int J Cancer, vol.99, pp.573-581, 2002.

H. Kobayashi, S. Dubois, and N. Sato, Role of transcellular IL-15 presentation in the activation of NK cellmediated killing, which leads to enhanced tumor immunosurveillance, Blood, vol.105, pp.721-728, 2005.

R. M. Teague, B. D. Sather, and J. A. Sacks, Interleukin-15 rescues tolerant CD8 + T cells for use in adoptive immunotherapy of established tumors, Nat Med, vol.12, pp.335-376, 2006.

C. A. Klebanoff, S. E. Finkelstein, and D. R. Surman, IL-15 enhances the in vivo antitumor activity of tumorreactive CD8 + T cells, Proc Natl Acad Sci U S A, vol.101, pp.1969-74, 2004.

T. A. Fehniger, K. Suzuki, and A. Ponnappan, Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8 + T cells, J Exp Med, vol.193, pp.219-250, 2001.

G. Baldassarre, M. Fedele, and S. Battista, Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway, Proc Natl Acad Sci U S A, vol.98, pp.7970-7975, 2001.

M. Seike, N. Yanaihara, and E. D. Bowman, Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier, J Natl Cancer Inst, vol.99, pp.1257-69, 2007.

S. T. Nguyen, S. Hasegawa, and H. Tsuda, Identification of a predictive gene expression signature of cervical lymph node metastasis in oral squamous cell carcinoma, Cancer Sci, vol.98, pp.740-746, 2007.

C. Badoual, S. Hans, and J. Rodriguez, Prognostic value of tumor-infiltrating CD4 + T-cell subpopulations in head and neck cancers, Clin Cancer Res, vol.12, pp.465-72, 2006.

C. Allen, S. Duffy, and T. Teknos, Nuclear factor-nBrelated serum factors as longitudinal biomarkers of response and survival in advanced oropharyngeal carcinoma, Clin Cancer Res, vol.13, pp.3182-90, 2007.

J. S. Wolf, G. Li, and A. Varadhachary, Oral lactoferrin results in T cell-dependent tumor inhibition of head and neck squamous cell carcinoma in vivo, Clin Cancer Res, vol.13, pp.1601-1611, 2007.

E. Mortier, J. Bernard, A. Plet, and Y. Jacques, Natural, proteolytic release of a soluble form of human IL-15 receptor a-chain that behaves as a specific, high affinity IL-15 antagonist, J Immunol, vol.173, pp.1681-1689, 2004.
URL : https://hal.archives-ouvertes.fr/inserm-02437358

V. Budagian, E. Bulanova, and Z. Orinska, Natural soluble interleukin-15Ra is generated by cleavage that involves the tumor necrosis factor-a-converting enzyme (TACE/ADAM17), J Biol Chem, vol.279, pp.40368-75, 2004.

E. Bulanova, V. Budagian, and E. Duitman, Soluble interleukin IL-15Ra is generated by alternative splicing or proteolytic cleavage and forms functional complexes with IL-15, J Biol Chem, vol.282, pp.13167-79, 2007.

R. Ruckert, K. Brandt, and A. Braun, Blocking IL-15 prevents the induction of allergen-specific T cells and allergic inflammation in vivo, J Immunol, vol.174, pp.5507-5522, 2005.

X. G. Smith, E. M. Bolton, and H. Ruchatz, Selective blockade of IL-15 by soluble IL-15 receptor a-chain enhances cardiac allograft survival, J Immunol, vol.165, pp.344-450, 2000.

E. Mortier, A. Quemener, and P. Vusio, Soluble interleukin-15 receptor a (IL-15Ra)-sushi as a selective and potent agonist of IL-15 action through IL-15Rh/g. Hyperagonist IL-15 Â IL-15Ra fusion proteins, J Biol Chem, vol.281, pp.1612-1621, 2006.

F. Benchetrit, A. Ciree, and V. Vives, Interleukin-17 inhibits tumor cell growth by means of a T-celldependent mechanism, Blood, vol.99, pp.2114-2135, 2002.

E. Tartour, V. Mosseri, and T. Jouffroy, Serum soluble interleukin-2 receptor concentrations as an independent prognostic marker in head and neck cancer, Lancet, vol.357, pp.1263-1267, 2001.

S. Wittnebel, D. Rocha, S. Giron-michel, and J. , Membrane-bound interleukin (IL)-15 on renal tumor cells rescues natural killer cells from IL-2 starvationinduced apoptosis, Cancer Res, vol.67, pp.5594-5603, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00158208

A. Anichini, A. Scarito, A. Molla, G. Parmiani, and R. Mortarini, Differentiation of CD8 + T cells from tumor-invaded and tumor-free lymph nodes of melanoma patients: role of common g-chain cytokines, J Immunol, vol.171, pp.2134-2175, 2003.

E. Tartour, F. Fossiez, and I. Joyeux, Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice, Cancer Res, vol.59, pp.3698-704, 1999.

M. Numasaki, J. Fukushi, and M. Ono, Interleukin-17 promotes angiogenesis and tumor growth, Blood, vol.101, pp.2620-2627, 2003.

T. A. Stoklasek, K. S. Schluns, and L. Lefrancois, Combined IL-15/IL-15Ra immunotherapy maximizes IL-15 activity in vivo, J Immunol, vol.177, pp.6072-80, 2006.

M. P. Rubinstein, M. Kovar, and J. F. Purton, Converting IL-15 to a superagonist by binding to soluble IL-15Ra, Proc Natl Acad Sci, vol.103, pp.9166-71, 2006.

J. Bernard, C. Harb, and E. Mortier, Identification of an interleukin-15a receptor-binding site on human interleukin-15, J Biol Chem, vol.279, pp.24313-24335, 2004.

J. Giron-michel, M. Giuliani, and M. Fogli, Membranebound and soluble IL-15/IL-15Ra complexes display differential signaling and functions on human hematopoietic progenitors, Blood, vol.106, pp.2302-2312, 2005.

C. Becker, M. C. Fantini, and C. Schramm, TGF-h suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling, Immunity, vol.21, pp.491-501, 2004.

S. Oh, L. P. Perera, D. S. Burke, T. A. Waldmann, and J. A. Berzofsky, IL-15/IL-15Ra-mediated avidity maturation of memory CD8 + T cells, Proc Natl Acad Sci U S A, vol.101, pp.15154-15163, 2004.

M. R. Young, Protective mechanisms of head and neck squamous cell carcinomas from immune assault, Head Neck, vol.28, pp.462-70, 2006.

T. E. Reichert, L. Strauss, E. M. Wagner, W. Gooding, and T. L. Whiteside, Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma, Clin Cancer Res, vol.8, pp.3137-3182, 2002.

T. K. Hoffmann, G. Dworacki, and T. Tsukihiro, Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance, Clin Cancer Res, vol.8, pp.2553-62, 2002.

H. Yu, M. Kortylewski, and D. Pardoll, Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment, Nat Rev Immunol, vol.7, pp.41-51, 2007.

C. H. Druzgal, Z. Chen, and N. T. Yeh, A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma, Head Neck, vol.27, pp.771-84, 2005.

H. Kuniyasu, H. Ohmori, and T. Sasaki, Production of interleukin 15 by human colon cancer cells is associated with induction of mucosal hyperplasia, angiogenesis, and metastasis, Clin Cancer Res, vol.9, pp.4802-4812, 2003.

M. P. Colombo and A. Mantovani, Targeting myelomonocytic cells to revert inflammation-dependent cancer promotion, Cancer Res, vol.65, pp.9113-9119, 2005.

K. E. De-visser, A. Eichten, and L. M. Coussens, Paradoxical roles of the immune system during cancer development, Nat Rev Cancer, vol.6, pp.24-37, 2006.

Q. Li, S. Withoff, and I. M. Verma, Inflammation-associated cancer: NF-nB is the lynchpin, Trends Immunol, vol.26, pp.318-343, 2005.

T. Lawrence, T. Hageman, and F. Balkwill, Cancer. Sex, cytokines, and cancer. Science, vol.317, pp.51-53, 2007.

W. W. Lin and M. Karin, A cytokine-mediated link between innate immunity, inflammation, and cancer, J Clin Invest, vol.117, pp.1175-83, 2007.

A. Handisurya, G. E. Steiner, and U. Stix, Differential expression of interleukin-15, a pro-inflammatory cytokine and T-cell growth factor, and its receptor in human prostate, Prostate, vol.49, pp.251-62, 2001.

P. A. Kenny and M. J. Bissell, Targeting TACE-dependent EGFR ligand shedding in breast cancer, J Clin Invest, vol.117, pp.337-382, 2007.

J. S. Fridman, E. Caulder, and M. Hansbury, Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancer, Clin Cancer Res, vol.13, pp.1892-902, 2007.